Investigation of the Relationship Between Central Sensitization and Balance in Fibromyalgia

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-65
SponsorSultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey

About this trial

The aim of the study is to investigate the relationship between central sensitization parameters and changes in static and dynamic balance in patients with fibromyalgia.

The main questions it aims to answer are:

* Do central sensitization parameters differ in patients with fibromyalgia compared to healthy individuals? * How is balance performance in these individuals compared to healthy controls? * Do central sensitization parameters affect static and dynamic balance in patients with fibromyalgia? * Do central sensitization parameters lead to quantitative changes in balance in patients with fibromyalgia?

Eligibility criteria

Qualifiers

Diagnosis of FMS according to the ACR 2016 diagnostic criteria

Being between the ages of 18 and 65

Being literate

Providing informed consent by signing the voluntary consent form

Disqualifiers

Being under 18 years old or over 65 years old

Presence of vestibular disorders

Having undergone spinal and/or extremity surgery (such as for back/hip/knee/foot) within the last 6 months

History of lower extremity amputation

Trial design

Treatments tested in this trial

  • Biodex Balance System
  • Pressure Pain Threshold (PPT) Measurement with Algometer
  • Conditioned Pain Modulation (CPM)
  • Slowly Repeated Evoked Pain Assessment Protocol (SREP)
  • Central Sensitization Inventory (CSI)
  • Numeric Rating Scale (NRS)
  • Revised Fibromyalgia Impact Questionnaire (FIQ)
  • S-LANSS Pain Score (Self-administered Leeds Assessment of Neuropathic Symptoms and Signs)
  • Tampa Kinesiophobia Scale (TKS)
  • Hospital Anxiety and Depression Scale (HAD)
  • SF-12 Health Survey (SF-12 Quality of Life Scale)
  • Fatigue Severity Scale (FSS)
  • Timed Up and Go Test (TUG)

Treatment groups

75 Participants
are divided into 2 treatment groups